Evidence map›Paper›PMID 28656686›Full record

ArticleStatistics in medicine2017

Estimation of genetic risk function with covariates in the presence of missing genotypes.

Annie J Lee, Karen Marder, Roy N Alcalay, Helen Mejia-Santana, Avi Orr-Urtreger, Nir Giladi, Susan Bressman, Yuanjia Wang

Abstract read
In one paragraph

Article in Statistics in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease.Annals of clinical and translational neurology · 2023
    Article
  2. Article
  3. Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.Movement disorders : official journal of the Movement Disorder Society · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Annie J LeeDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, U.S.A.ORCID http://orcid.org/0000-0003-3726-6024
Karen MarderDepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, U.S.A.
Roy N AlcalayDepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, U.S.A.
Helen Mejia-SantanaDepartment of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, U.S.A.
Avi Orr-UrtregerSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Nir GiladiSagol School for Neurosciences, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Susan BressmanDepartment of Neurology, Mount Sinai Beth Israel Medical Center, New York, NY, U.S.A.
Yuanjia WangDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, U.S.A.ORCID http://orcid.org/0000-0002-1510-3315
Columbia University · USNew York University · USTel Aviv University · ILMount Sinai Beth Israel · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
GENETIC EPIDEMIOLOGY OF PARKINSONS DISEASER01NS036630 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARDER, KAREN S · 1998 to 2008
$6.8M
Statistical Methods for Integrating Mixed-type Biomarkers and Phenotypes in Neurodegenerative Disease ModelingR01NS073671 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2011 to 2025
$3.9M
Identifying Huntington's disease markers by modern statistical learning methods.U01NS082062 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, YUANJIA · 2014 to 2016
$1.1M
The role of glucocerebrosidase in Parkinson's diseaseK02NS080915 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ALCALAY, ROY · 2012 to 2016
$905k
Clinical and Translational Science AwardTL1TR000082 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$732k
Genetic Epidemiology of Parkinson's DiseaseR56NS036630 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARDER, KAREN S · 2010 to 2010
$500k
Efficient Statistical Methods for Association Studies with Dense Genotypes and Family History of DiseaseF31AG054095 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEE, ANNIE J · 2016 to 2018
$122k
NCATS NIH HHS TL1 TR000082NCRR NIH HHS UL1 RR024156NIA NIH HHS F31 AG054095NINDS NIH HHS K02 NS080915NINDS NIH HHS R01 NS036630NINDS NIH HHS R01 NS073671NINDS NIH HHS R56 NS036630NINDS NIH HHS U01 NS082062
6 · The paper itself

Abstract

In genetic epidemiological studies, family history data are collected on relatives of study participants and used to estimate the age-specific risk of disease for individuals who carry a causal mutation. However, a family member's genotype data may not be collected because of the high cost of in-person interview to obtain blood sample or death of a relative. Previously, efficient nonparametric genotype-specific risk estimation in censored mixture data has been proposed without considering covariates. With multiple predictive risk factors available, risk estimation requires a multivariate model to account for additional covariates that may affect disease risk simultaneously. Therefore, it is important to consider the role of covariates in genotype-specific distribution estimation using family history data. We propose an estimation method that permits more precise risk prediction by controlling for individual characteristics and incorporating interaction effects with missing genotypes in relatives, and thus, gene-gene interactions and gene-environment interactions can be handled within the framework of a single model. We examine performance of the proposed methods by simulations and apply them to estimate the age-specific cumulative risk of Parkinson's disease (PD) in carriers of the LRRK2 G2019S mutation using first-degree relatives who are at genetic risk for PD. The utility of estimated carrier risk is demonstrated through designing a future clinical trial under various assumptions. Such sample size estimation is seen in the Huntington's disease literature using the length of abnormal expansion of a CAG repeat in the HTT gene but is less common in the PD literature. Copyright © 2017 John Wiley & Sons, Ltd.

Indexed as

Genetic Predisposition to DiseaseModels, GeneticModels, StatisticalAgedAged, 80 and overComputer SimulationFamilyFemaleGene-Environment InteractionGenotypeHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Likelihood FunctionsMaleMiddle AgedMutationLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humancensored datadisease risk estimationmixture distributionParkinson's diseasepenetrance function

Identifiers

PMID28656686
PMCPMC5583003
OpenAlexW2619164347

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.